Renese
Name: Renese
Renese Overview
Renese is a brand name medication included in a group of medications called Thiazides, plain. For more information about Renese see its generic Polythiazide
Contraindications
Anuria. Hypersensitivity to this or other sulfonamide derived drugs.
How is Renese Supplied
Renese (polythiazide) Tablets are available as:
1 mg white, scored tablets in bottles of 100 (NDC 0069-3750-66).
2 mg yellow, scored tablets in bottles of 100 (NDC 0069-3760-66).
4 mg white, scored tablets in bottles of 100 (NDC 0069-3770-66).
Rx Only
69-1116-00-6
April 1997
Renese polythiazide tablet |
Product Information | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:0069-3750 | Route of Administration | ORAL | DEA Schedule | | |
Active Ingredient/Active Moiety | Ingredient Name | Basis of Strength | Strength | polythiazide (polythiazide) | polythiazide | 1 mg | |
Inactive Ingredients | Ingredient Name | Strength | dibasic calcium phosphate | | lactose | | magnesium stearate | | polyethylene glycol | | sodium lauryl sulfate | | starch | | vanillin | | |
Product Characteristics | Color | WHITE (White) | Score | 2 pieces | Shape | ROUND (Round) | Size | 7mm | Flavor | | Imprint Code | Pfizer;375 | Contains | | Coating | false | Symbol | false | |
Packaging | # | Item Code | Package Description | 1 | NDC:0069-3750-66 | 100 TABLET (100 TABLET) in BOTTLE | |
|
|
Renese polythiazide tablet |
Product Information | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:0069-3760 | Route of Administration | ORAL | DEA Schedule | | |
Active Ingredient/Active Moiety | Ingredient Name | Basis of Strength | Strength | polythiazide (polythiazide) | polythiazide | 2 mg | |
Inactive Ingredients | Ingredient Name | Strength | dibasic calcium phosphate | | lactose | | magnesium stearate | | polyethylene glycol | | sodium lauryl sulfate | | starch | | vanillin | | yellow 6 | | yellow 10 | | |
Product Characteristics | Color | YELLOW (Yellow) | Score | 2 pieces | Shape | ROUND (Round) | Size | 9mm | Flavor | | Imprint Code | Pfizer;376 | Contains | | Coating | false | Symbol | false | |
Packaging | # | Item Code | Package Description | 1 | NDC:0069-3760-66 | 100 TABLET (100 TABLET) in BOTTLE | |
|
|
Renese polythiazide tablet |
Product Information | Product Type | HUMAN PRESCRIPTION DRUG LABEL | Item Code (Source) | NDC:0069-3770 | Route of Administration | ORAL | DEA Schedule | | |
Active Ingredient/Active Moiety | Ingredient Name | Basis of Strength | Strength | polythiazide (polythiazide) | polythiazide | 4 mg | |
Inactive Ingredients | Ingredient Name | Strength | dibasic calcium phosphate | | lactose | | magnesium stearate | | polyethylene glycol | | sodium lauryl sulfate | | starch | | vanillin | | |
Product Characteristics | Color | WHITE (White) | Score | 2 pieces | Shape | ROUND (Round) | Size | 9mm | Flavor | | Imprint Code | Pfizer;377 | Contains | | Coating | false | Symbol | false | |
Packaging | # | Item Code | Package Description | 1 | NDC:0069-3770-66 | 100 TABLET (100 TABLET) in BOTTLE | |
|
|
Revised: 12/2005 Pfizer Labs
Polythiazide Breastfeeding Warnings
While there are no data on polythiazide, many other thiazide diuretic agents are known to be excreted into human milk in low concentrations. Although a rare case of thrombocytopenia has been reported in one nursing infant whose mother was taking chlorothiazide, adverse effects in nursing infants are unlikely. However, the manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.